on 30 Apr 2024
Last Applicant/ Owned by
Cambridge MA 02140
US
Serial Number
79349914 filed on 15th Jul 2022
Registration Number
7369446 registered on 30th Apr 2024
Correspondent Address
MARK E. BANYRankin Hill & Clark, LLP
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
esign of computer databases; Conversion of computer programs and data, other than physical conversion; igitization of documents being scanning; Computer programming in medical care; Providing virtual computer systems through cloud computing; Pharmaceutical drug development; rug evaluation in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous anRead More
esign of computer databases; Conversion of computer programs and data, other than physical conversion; igitization of documents being scanning; Computer programming in medical care; Providing virtual computer systems through cloud computing; Pharmaceutical drug development; rug evaluation in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Pharmaceutical research; Scientific research and development; Conducting early evaluation of new drug fields in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Computer hardware design; Research and development of new products for others; Providing computer software design for others; Electronic data storage; Conducting technical project studies in the nature of technical research in the field of pharmaceutical studies; Conversion of data or documents from physical to electronic media; Clinical trials, namely, scientific research in the nature of conducting clinical trials for others; Animal genetics research in the nature of studying the mechanism of action of compound combinations in animals; Computer programming
Medicines for human purposes, namely, for use for central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney and gastrointestinal diseases; Pharmaceutical preparations, namely, for use for central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Chemico-pharmaceutical preparations, namely, for use for central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Capsules being medicines, namely, capsules for the treatment of central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney related diseases, gastrointestinal diseases; Sedatives; Vaccines; rugs for medical purposes, namely, central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Medicines in tablet form, namely, medicinal preparations for the mouth to be applied in the form of tablets; Injectable medicinal solutions, namely, powder for injection, parenteral solutions, solutions for injection, intravenous injections, suspensions for injection, sterile powders for injection, intravenous injections, emulsion for injection, emulsion injections, powder injections, and concentrated solutions for injection, all for the treatment of central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney and gastrointestinal diseases; Pain relief medication; Immunostimulants; Pharmaceuticals for the treatment of cancer; Pharmaceuticals for the treatment of infectious diseases; Pharmaceuticals for the treatment of viral diseases; Medicinal preparations for the treatment of musculoskeletal disorders; rugs and preparations for the treatment of gastrointestinal diseases; Medicinal preparations for skin diseases
No 79349914
No Service Mark
No LIU-54670
No
No
No
No
Yes
Yes
No
No
05.03.25 -
Other leaves
15.05.07 -
Computer processing and data storage devices, not including computer terminals or devices or media for mere storage or playback of data, audio, or video
| Status Date | Action Taken |
|---|---|
| 30th Apr 2024 | REGISTERE-PRINCIPAL REGISTER |
| 30th Apr 2024 | NOTICE O REGISTRATION CONIRMATION EMAILE |
| 11th Mar 2024 | NOTIICATION O POSSIBLE OPPOSITION - PROCESSE BY IB |
| 21st Feb 2024 | NOTIICATION O POSSIBLE OPPOSITION CREATE, TO BE SENT TO IB |
| 21st Feb 2024 | NOTIICATION O POSSIBLE OPPOSITION SENT TO IB |
| 14th Feb 2024 | NOTIICATION PROCESSE BY IB |
| 13th Feb 2024 | OICIAL GAZETTE PUBLICATION CONIRMATION E-MAILE |
| 13th Feb 2024 | PUBLISHE OR OPPOSITION |
| 24th Jan 2024 | NOTICE O START O OPPOSITION PERIO CREATE, TO BE SENT TO IB |
| 24th Jan 2024 | NOTIICATION O NOTICE O PUBLICATION E-MAILE |
